These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 32692459)
1. Use of proton pump inhibitors is associated with lower rates of first-time ischemic stroke in community-dwelling elderly. Schmilovitz-Weiss H; Gingold-Belfer R; Peleg N; Grossman A; Issa N; Boltin D; Beloosesky Y; Koren-Morag N; Meyerovitch J; Shirin H; Weiss A Br J Clin Pharmacol; 2021 Mar; 87(3):1187-1193. PubMed ID: 32692459 [TBL] [Abstract][Full Text] [Related]
2. Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction. Sehested TSG; Gerds TA; Fosbøl EL; Hansen PW; Charlot MG; Carlson N; Hlatky MA; Torp-Pedersen C; Gislason GH J Intern Med; 2018 Mar; 283(3):268-281. PubMed ID: 29024109 [TBL] [Abstract][Full Text] [Related]
3. Concomitant Use of Proton Pump Inhibitors and Clopidogrel Is Not Associated with Adverse Outcomes after Ischemic Stroke in Chinese Population. Yi X; Zhou Q; Wang C; Lin J; Cheng W; Chi L J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2859-2867. PubMed ID: 27546731 [TBL] [Abstract][Full Text] [Related]
4. Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study. Wang YF; Chen YT; Luo JC; Chen TJ; Wu JC; Wang SJ Am J Gastroenterol; 2017 Jul; 112(7):1084-1093. PubMed ID: 28397874 [TBL] [Abstract][Full Text] [Related]
5. Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: Results From the PARIS Registry. Chandrasekhar J; Bansilal S; Baber U; Sartori S; Aquino M; Farhan S; Vogel B; Faggioni M; Giustino G; Ariti C; Colombo A; Chieffo A; Kini A; Saporito R; Michael Gibson C; Witzenbichler B; Cohen D; Moliterno D; Stuckey T; Henry T; Pocock S; Dangas G; Gabriel Steg P; Mehran R Catheter Cardiovasc Interv; 2017 Jun; 89(7):E217-E225. PubMed ID: 27650638 [TBL] [Abstract][Full Text] [Related]
6. No Significant Association Between Proton Pump Inhibitor Use and Risk of Stroke After Adjustment for Lifestyle Factors and Indication. Nguyen LH; Lochhead P; Joshi AD; Cao Y; Ma W; Khalili H; Rimm EB; Rexrode KM; Chan AT Gastroenterology; 2018 Apr; 154(5):1290-1297.e1. PubMed ID: 29269313 [TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events. Fortuna LA; Pawloski PA; Parker ED; Trower NK; Kottke TE Eur Heart J Cardiovasc Pharmacother; 2016 Jan; 2(1):13-9. PubMed ID: 27533057 [TBL] [Abstract][Full Text] [Related]
8. Proton Pump Inhibitor Use and the Risk of Cardiovascular Complications and Death in Older Adults with Diabetes: A Population-Based Cohort Study. Foresta A; Fernandez LO; Torrigiani G; Schena S; Roncaglioni MC; Nobili A; Tettamanti M; Franchi C; Fortino I; Succurro E; Sesti G; Baviera M Drugs Aging; 2024 Mar; 41(3):239-249. PubMed ID: 38367169 [TBL] [Abstract][Full Text] [Related]
9. Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry. Hoedemaker NPG; Damman P; Ottervanger JP; Dambrink JHE; Gosselink ATM; Kedhi E; Kolkman E; de Winter RJ; van 't Hof AWJ Eur Heart J Cardiovasc Pharmacother; 2019 Jul; 5(3):127-138. PubMed ID: 30084902 [TBL] [Abstract][Full Text] [Related]
10. Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors. Leonard CE; Bilker WB; Brensinger CM; Flockhart DA; Freeman CP; Kasner SE; Kimmel SE; Hennessy S Stroke; 2015 Mar; 46(3):722-31. PubMed ID: 25657176 [TBL] [Abstract][Full Text] [Related]
11. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding. Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493 [TBL] [Abstract][Full Text] [Related]
12. Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial. Goodman SG; Clare R; Pieper KS; Nicolau JC; Storey RF; Cantor WJ; Mahaffey KW; Angiolillo DJ; Husted S; Cannon CP; James SK; Kilhamn J; Steg PG; Harrington RA; Wallentin L; Circulation; 2012 Feb; 125(8):978-86. PubMed ID: 22261200 [TBL] [Abstract][Full Text] [Related]
13. Lack of Association Between Proton Pump Inhibitor Use and Cognitive Decline. Wod M; Hallas J; Andersen K; García Rodríguez LA; Christensen K; Gaist D Clin Gastroenterol Hepatol; 2018 May; 16(5):681-689. PubMed ID: 29391266 [TBL] [Abstract][Full Text] [Related]
14. Current status of proton pump inhibitor use in Japanese elderly patients with non-valvular atrial fibrillation: A subanalysis of the ANAFIE Registry. Mizokami Y; Yamamoto T; Atarashi H; Yamashita T; Akao M; Ikeda T; Koretsune Y; Okumura K; Shimizu W; Tsutsui H; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Inoue H PLoS One; 2020; 15(11):e0240859. PubMed ID: 33151969 [TBL] [Abstract][Full Text] [Related]
15. Outcomes with concurrent use of clopidogrel and proton-pump inhibitors: a cohort study. Ray WA; Murray KT; Griffin MR; Chung CP; Smalley WE; Hall K; Daugherty JR; Kaltenbach LA; Stein CM Ann Intern Med; 2010 Mar; 152(6):337-45. PubMed ID: 20231564 [TBL] [Abstract][Full Text] [Related]
16. Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation. Schmidt M; Johansen MB; Robertson DJ; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Sørensen HT; Baron JA Aliment Pharmacol Ther; 2012 Jan; 35(1):165-74. PubMed ID: 22050009 [TBL] [Abstract][Full Text] [Related]
17. Chronic omeprazole use in the elderly is associated with decreased risk of dementia and cognitive decline. Weiss A; Gingold-Belfer R; Boltin D; Beloosesky Y; Koren-Morag N; Meyerovitch J; Sharon E; Schmilovitz-Weiss H Dig Liver Dis; 2022 May; 54(5):622-628. PubMed ID: 34949554 [TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study. Lin SM; Yang SH; Liang CC; Huang HK Osteoporos Int; 2018 Jan; 29(1):153-162. PubMed ID: 29032384 [TBL] [Abstract][Full Text] [Related]
19. Use of proton pump inhibitors is associated with lower trabecular bone density in older individuals. Maggio M; Lauretani F; Ceda GP; De Vita F; Bondi G; Corsonello A; Cattabiani C; Lattanzio F; Ruggiero C; Nouvenne A; Meschi T; Bandinelli S; Ferrucci L Bone; 2013 Dec; 57(2):437-42. PubMed ID: 24076021 [TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials. O'Donoghue ML; Braunwald E; Antman EM; Murphy SA; Bates ER; Rozenman Y; Michelson AD; Hautvast RW; Ver Lee PN; Close SL; Shen L; Mega JL; Sabatine MS; Wiviott SD Lancet; 2009 Sep; 374(9694):989-997. PubMed ID: 19726078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]